Financials

News Ideas Discussions Technicals Forecast Seasonals Bonds

RVNC fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Revance Therapeutics, Inc.

Total assets of RVNC for Q2 24 is 494.80 M USD, 2.62% less than the previous Q1 24. And total liabilities increased by 2.92% in Q2 24 to 624.54 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—